Hepatitis B surface antigen glycan isomer as a new potential biomarker in patients with hepatitis B virus infection

被引：0
|
作者：
Okumura, Taiki [1 ]
Umemura, Takeji [1 ]
机构：
[1] Shinshu Univ, Sch Med, Dept Med, Div Gastroenterol & Hepatol, 3-1-1 Asah, Matsumoto, Nagano 3908621, Japan
来源：
HEPATOLOGY RESEARCH | 2024年 / 54卷 / 10期
关键词：
hepatitis B surface antigen glycan isomer; hepatitis B virus; hepatocellular carcinoma; nucleos(t)ide analog; NATURAL-HISTORY; RISK;
D O I：
10.1111/hepr.14106
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：874 / 876
页数：3
相关论文
共 50 条
  • [31] Quantification of hepatitis B surface antigen: a new concept for the management of chronic hepatitis B
    Moucari, Rami
    Marcellin, Patrick
    LIVER INTERNATIONAL, 2011, 31 : 122 - 128
  • [32] Hepatitis B Surface Antigen Quantification across Different Phases of Chronic Hepatitis B Virus Infection Using an Immunoradiometric Assay
    Chung, Kwang Hyun
    Kim, Won
    Kim, Byeong Gwan
    Lee, Ho-Young
    Jin, Eunhyo
    Cho, Yuri
    Seo, Ji Yeon
    Kim, Hwi Young
    Jung, Yong Jin
    Kim, Ji Won
    Jeong, Ji Bong
    Lee, Kook Lae
    GUT AND LIVER, 2015, 9 (05) : 657 - 664
  • [33] Effect of serum hepatitis B surface antigen levels on predicting the clinical outcomes of chronic hepatitis B infection: A meta-analysis
    Qu, Li-Shuai
    Liu, Jin-Xia
    Zhang, Hai-Feng
    Zhu, Jing
    Lu, Cui-Hua
    HEPATOLOGY RESEARCH, 2015, 45 (09) : 1004 - 1013
  • [34] Hepatitis B surface antigen predicts recurrence after radiofrequency ablation in patients with low hepatitis B virus loads
    Zhang, Lan
    Xie, Xiao-Ying
    Chen, Yi
    Ge, Ning-Ling
    Chen, Rong-Xin
    Gan, Yu-Hong
    Zhang, Bo-Heng
    Wang, Yan-Hong
    Ren, Zheng-Gang
    MEDICINE, 2017, 96 (52)
  • [35] Hepatitis B surface antigen glycan isomer is a predictor of the development of hepatocellular carcinoma during nucleoside/nucleotide analog therapy
    Kozuka, Ritsuzo
    Enomoto, Masaru
    Yukawa-Muto, Yoshimi
    Odagiri, Naoshi
    Kotani, Kohei
    Motoyama, Hiroyuki
    Kawamura, Etsushi
    Hagihara, Atsushi
    Fujii, Hideki
    Uchida-Kobayashi, Sawako
    Kawada, Norifumi
    HEPATOLOGY RESEARCH, 2024, 54 (07) : 615 - 626
  • [36] Effect of immune checkpoint inhibitors on patients with hepatitis B virus infection
    Mon, Hsien-Chen
    Lee, Pei-Chang
    Chi, Chen-Ta
    Huang, Yi-Hsiang
    JOURNAL OF THE CHINESE MEDICAL ASSOCIATION, 2025, 88 (02) : 93 - 97
  • [37] Controversies in Treating Chronic Hepatitis B virus The Role of Hepatitis B Virus DNA and Surface Antigen Titer
    Huang, Daniel Q.
    Kew, Guan Sen
    Lim, Seng Gee
    CLINICS IN LIVER DISEASE, 2021, 25 (04) : 763 - 784
  • [38] Capabilities of hepatitis B surface antigen are divergent from hepatitis B virus DNA in delimiting natural history phases of chronic hepatitis B virus infection
    Zhang, Zhanqing
    Lu, Wei
    Huang, Dan
    Zhou, Xinlan
    Ding, Rongrong
    Li, Xiufen
    Wang, Yanbing
    Lin, Weijia
    Zeng, Dong
    Feng, Yanling
    FRONTIERS IN IMMUNOLOGY, 2022, 13
  • [39] Low Hepatitis B Core-Related Antigen Levels Correlate Higher Spontaneous Seroclearance of Hepatitis B Surface Antigen in Chronic Hepatitis B Patients With High Hepatitis B Surface Antigen Levels
    Tseng, Tai-Chung
    Chiang, Chieh
    Liu, Chun-Jen
    Hong, Chun-Ming
    Su, Tung-Hung
    Yang, Hung-Chih
    Yang, Wan-Ting
    Liu, Chen-Hua
    Chen, Pei-Jer
    Kao, Jia-Horng
    GASTROENTEROLOGY, 2023, 164 (04) : 669 - 679.e6
  • [40] Chronic Hepatitis B Virus Infection
    McMahon, Brian J.
    MEDICAL CLINICS OF NORTH AMERICA, 2014, 98 (01) : 39 - +
12345